Sign in

James D. Frias

Director at CARLISLE COMPANIESCARLISLE COMPANIES
Board

About James D. Frias

Retired finance executive with deep manufacturing and M&A experience; age 68 and a continuing director of Carlisle Companies Incorporated (CSL) since February 2015, with his current term expiring in 2027 . Former CFO, Treasurer and EVP of Nucor Corporation (2010–2022) and Corporate Controller (2001–2009), and designated “Audit Committee Financial Expert”; identified strengths include international business, M&A, manufacturing, and corporate governance .

Past Roles

OrganizationRoleTenureCommittees/Impact
Nucor CorporationChief Financial Officer, Treasurer & EVPJan 2010 – Mar 2022Principal financial officer; extensive M&A, JV transactions, new facilities, commercialization of new technology
Nucor CorporationCorporate ControllerJun 2001 – Dec 2009Financial controls and accounting leadership at major steel manufacturer

External Roles

OrganizationRoleTenureNotes
No other public company directorships disclosed for Mr. Frias in CSL’s 2025 proxy .

Board Governance

AttributeDetail
IndependenceBoard determined Mr. Frias is independent under CSL standards, NYSE and SEC rules (Dec 2024 review) .
Committee Assignments (current)Audit Committee Member; Corporate Governance & Nominating Committee Member .
Prior Committee ServiceServed on Compensation Committee in 2024 (interlocks section) .
Committee ChairsNone for Mr. Frias; current chairs are Myers (Audit), Ricard (Compensation), Adams (Corporate Governance & Nominating, also Lead Independent Director) .
AttendanceEach incumbent director attended all Board and applicable committee meetings in 2024; Board held six meetings, Audit (6), Compensation (3), Corporate Governance & Nominating (2) .
Lead Independent DirectorStructure in place; Mr. Adams presides over executive sessions at every regular Board meeting .
Retirement/Refreshment PolicyMandatory resignation at annual meeting following earlier of age 72 or 18 consecutive years of service; no exemptions .
Related Person TransactionsNone in 2024; Corporate Governance & Nominating Committee oversees any such items >$120,000 .
Hedging PolicyHedging of CSL equity prohibited for directors, officers, employees and designees .

Fixed Compensation

Component2024 Amount/Terms
Annual Board Retainer (policy)$125,000; directors may elect to receive up to half in Shares; no meeting fees .
Committee Chair Fees (policy)Audit Chair $25,000; Compensation Chair $20,000; Corporate Governance & Nominating Chair (Lead Independent Director) $45,000 .
Mr. Frias – Fees Earned (Cash)$128,750 .
Other Cash/PerqsDividends on unvested restricted shares: $1,927 .

Performance Compensation

ComponentGrant DetailsVesting/Performance Conditions
Annual Director Equity Grant451 restricted shares granted on April 30, 2024; grant date fair value ≈ $175,000 .Vests on earlier of 1 year from grant or retirement under Board policy (age 72 or 18 years of service) .
Deferred Compensation (Director Plan)Directors may defer up to 100% of cash fees and restricted shares; deferrals can be credited to Share equivalent units or a fixed-rate fund .Cash deferrals always 100% vested; restricted share deferrals vest per underlying award; paid after service ends .

Note: Non-employee director equity is time-vested and not tied to operating metrics; CSL’s performance metrics (Sales, Operating Income Margin, Average Working Capital % of Sales, Earnings/Adjusted Earnings) apply to executive annual incentives, not director pay .

Other Directorships & Interlocks

CategoryDetail
Other Public Company Boards (current)None disclosed for Mr. Frias .
CSL Compensation Committee ParticipationServed as a Compensation Committee member in 2024; no interlocking relationships disclosed .

Expertise & Qualifications

  • Designated “Audit Committee Financial Expert”; prior CFO experience of multinational business .
  • Significant manufacturing, M&A, corporate governance, and international business experience .
  • Background aligns with CSL’s building products focus; brings financial controls expertise .

Equity Ownership

ItemAmountAs-of
Shares Owned3,202 (includes 451 restricted shares) .Feb 28, 2025
Share Equivalent Units9,873 (no voting power; paid in Shares after service ends) .Feb 28, 2025
Total Beneficial Ownership13,075 (less than 1%) .Feb 28, 2025
Shares Outstanding44,149,183 .Feb 28, 2025
Ownership % of Outstanding≈0.03% (13,075 / 44,149,183) .
Director Stock Ownership PolicyRequires 5× annual fee ($125k) within 5 years; as of Dec 31, 2024, all directors with ≥5 years of service met the requirement (Mr. Frias joined in 2015) .

Governance Assessment

  • Board effectiveness: Independent director with 100% attendance and dual governance roles (Audit; Corporate Governance & Nominating); prior Compensation Committee service adds pay oversight experience .
  • Alignment: Annual restricted share grants and a robust director stock ownership policy (5× retainer) support skin-in-the-game; dividends on unvested shares are modest .
  • Conflicts/Red flags: No related-person transactions in 2024; hedging prohibited; no interlocks disclosed; independence re-affirmed in Dec 2024 .
  • Shareholder signals: 2024 say-on-pay support ~88%, indicating broad investor endorsement of compensation governance; committee chair rotation and lead independent structure further strengthen oversight .
  • Refreshment: Mandatory retirement at 72 or after 18 years promotes renewal; Mr. Frias (age 68; service since 2015) remains within policy parameters .

Overall: Mr. Frias presents as a financially sophisticated, independent director with strong attendance and governance credentials, low conflict risk, and equity alignment consistent with CSL’s policies—supportive of investor confidence in Board oversight .